Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

COPD (Chronic Obstructive Pulmonary Disease) Clinical Trials

A listing of COPD (Chronic Obstructive Pulmonary Disease) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (68) clinical trials

This study is basically comparing two products that are already on the market for patients with COPD, which includes chronic bronchitis and emphysema. The study lasts for approximately 6 months and compensation is provided for your time and travel.

Phase

This study will be a double-blind, randomized, placebo controlled, parallel-group study to evaluate the effect of Aclidinium bromide on the cardiovascular safety and COPD exacerbations in patients with moderate to very severe COPD, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria (GOLD, 2011). The Objectives ...

Phase

The objective of this study is: To assess the safety of aclidinium bromide on major adverse cardiovascular events (MACE). To assess the overall safety of aclidinium bromide. To assess whether aclidinium bromide reduces moderate or severe chronic obstructive pulmonary disease (COPD) exacerbations.

Phase

24 month duration visits every 6 months Lab testing physical exams pulmonary function testing chest x-ray increased COPD symptoms in the last 12 months requiring antibiotics or prednisone

Phase

This study will be a double-blind, randomized, placebo controlled, parallel-group study to evaluate the effect of Aclidinium bromide on the cardiovascular safety and COPD exacerbations in patients with moderate to very severe COPD, as defined by the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria (GOLD, 2011). The objectives ...

Phase

Are you experiencing Chronic Obstructive Pulmonary Disease (COPD)? Is your COPD moderate to severe you may be interested in learning more about a clinical research study that we are conducting.

Phase

Patient Inclusion Criteria: Must be between 40-80 years old and able to give consent Must have current diagnosis of moderate to severe COPD Current or prior cigarette smoking history of ≥10 pack-years Subjects must have a qualified cardiovascular indication Subjects must meet Spirometry measurements at screening Compensation will be made ...

Phase

We are currently conducting a clinical research study on an investigational inhaled medication in patients with chronic obstructive pulmonary disease (COPD). Eligible patients will receive study related medical exams and study medication at no cost while participating in the study. Compensation will also be provided for time and travel. Patient ...

Phase

The purpose of this study is to compare a FDA approved single therapy inhaler that combines 3 COPD medications to Spiriva for patient convenience. This study is about 3 months long and will consist of 6 office visits. All visits are conducted locally in Salt Lake City, Utah.

Phase

Utilizing Wearable Device to Observe the Clinical Response of COPD Patients Treated With Combined Bronchodilator and Home-based Pulmonary Rehabilitation Program

The prevalence of chronic obstructive pulmonary disease (COPD) has increased year by year and the estimated mortality rate by 2030 will be in the fourth place. Estimated global prevalence of COPD in the population over age 40 is about 9-10% of the population. In Taiwan, the prevalence is about 16%. ...

Phase